CoChat
Sign Up
Cited by 140

Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials

Rutherford, Bret R., Wall, Melanie M., Brown, Patrick J., Choo, Tse-Hwei, Wager, Tor D., Peterson, Bradley S., Chung, Sarah, Kirsch, Irving +1 more·2017·American Journal of Psychiatry
DOI 10.1176/appi.ajp.2016.16020225PMC PMC5288269
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1176/appi.ajp.2016.16020225

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 33

  1. [1]Khan A Bhat A Kolts R Thase ME Brown W Why has the Antidepressant-Placebo Difference in Antidepressant Clinical Trials Diminished over the Past Three Decades? CNS Neuroscience & Therapeutics 2010 16 217 226 20406269 PMC6493812
  2. [2]Khan A Khan S Brown WA Are placebo controls necessary to test new antidepressants and anxiolytics? Int J Neuropsychopharmacol 2002 5 193 197 12366872
  3. [3]Hooper M Amsterdam JD Do clinical trials reflect drug potential? A review of FDA evaluation of new antidepressants 39th Annual NCDEU Meeting Boca Raton June 11–14, 1998
  4. [5]Kirsch I Sapirstein G Listening to prozac but hearing placebo: A meta-analysis of antidepressant medication Prev Treat 1998 posted at http://journals.apa.org/prevention/volumeI/pre0010002a.html
  5. [7]Stewart-Williams S Podd J The placebo effect: dissolving the expectancy versus conditioning debate Psychol Bull 2004 30 324 340 14979775
  6. [9]Wager TD Rilling JK Smith EE Sokolik A Casey KL Davidson RJ Kosslyn SM Rose RM Cohen JD Placebo-induced changes in fmri in the anticipation and experience of pain Science 2004 303 1162 1167 14976306
  7. [10]Benedetti F Mayberg HS Wager TD Stohler CS Zubieta ZK Neurobiological Mechanisms of the Placebo Effect J Neurosci 2005 25 10390 10402 16280578 PMC6725834
  8. [11]Rutherford BR Roose SP A Model of Placebo Effects in Antidepressant Clinical Trials Am J Psychiatry 2013 170 723 733 23318413 PMC3628961
  9. [12]Rutherford BR Sneed JR Roose SP Does Study Design Affect Outcome? The Effects of Placebo Control and Treatment Duration in Antidepressant Trials Psychother Psychosom 2009 78 172 181 19321970 PMC3785090
  10. [13]Sneed JR Rutherford BR Rindskopf D Roose SP Design Makes a Difference: A Meta-Analysis of Antidepressant Response Rates in Placebo-Controlled versus Comparator Trials in Late-Life Depression Am J Geri Psychiatry 2008 16 65 73 17998306
  11. [14]Papakostas GI Fava M Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD Eur Neuropsychopharm 2009 19 34 40 18823760
  12. [15]Sinyor M Levitt AJ Cheung AH Schaffer A Kiss A Dowlati Y Lanctot KL Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials? Results from Pooled and Meta-Analyses J Clin Psychiatry 2010 71 270 279 20122371
  13. [16]Rutherford BR Marcus SM Wang P Sneed JR Pelton GH Devanand DP Duan N Roose SP A Randomized, Prospective Pilot Study of Patient Expectancy and Antidepressant Outcome Psychol Med 2013 43 975 982 22971472 PMC3594112
  14. [18]Feighner JP Overo K Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression J Clin Psychiatry 1999 60 824 830 10665628
  15. [19]Patris M Bouchard JM Citalopram versus fluoxetine: a double-blind, controlled, multicentre, phase III trial in patients with unipolar major depression treated in general practice Int Clin Psychopharm 1996 11 129 136 8803650
  16. [20]Paykel ES Ramana R Cooper Z Hayhurst H Kerr J Barocka A Residual symptoms after partial remission: an important outcome in depression Psychol Med 1995 25 1171 1180 8637947
  17. [21]Kennedy N Paykel ES Residual symptoms at remission from depression: impact on long-term outcome J Affect Disord 2004 80 135 144 15207926
  18. [22]First MB Spitzer RL Gibbon M Williams JBW Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) 1996 American Psychiatric Press, Inc. Washington, D.C.
  19. [26]Walsh BT Seidman SN Sysko R Gould M Placebo Response in Studies of Major Depression: Variable, Substantial, and Growing JAMA 2002 287 1840 1847 11939870
  20. [27]Rutherford BR Cooper TM Persaud A Brown PJ Sneed JR Roose SP Less is More in Antidepressant Clinical Trials: A Meta-Analysis of the Effect of Visit Frequency on Treatment Response and Drop-out J Clin Psychiatry 2013 74 703 715 23945448 PMC3898620
  21. [28]Leuchter AF Hunter AM Tartter M Cook IA Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression Br J Psychiatry 2014 205 443 449 25213159 PMC4248233
  22. [29]Meyer B Pilkonis PA Krupnick JL Egan MK Simmens SJ Sotsky SM Treatment Expectancies, Patient Alliance, and Outcome: Further Analyses from the National Institute of Mental Health Treatment of Depression Collaborative Research Program J Consult Clin Psychol 2002 70 1051 1055 12182269
  23. [30]Krell HV Leuchter AF Morgan M Cook IA Abrams M Subject Expectations of Treatment Effectiveness and Outcome of Treatment with an Experimental Antidepressant J Clin Psychiatry 2004 65 1174 1179 15367043
  24. [31]Atlas LY Whittington RA Lindquist MA Wielgosz J Sonty N Wager TD Dissociable influences of opiates and expectations on pain J Neurosci 2012 32 8053 8064 22674280 PMC3387557
  25. [32]Bingel U Wanigasekera V Wiech K Ni Mhuircheartaigh R Lee MC Ploner M Tracey I The Effect of Treatment Expectation on Drug Efficacy: Imaging the Analgesic Benefit of the Opioid Remifentanil Sci Transl Med 2011 3 70ra14 21325618
  26. [36]Sexton H Exploring a psychotherapeutic change sequence relating process to intersessional and posttreatment outcome J Consult Clin Psychol 1993 61 128 136 8450098
  27. [37]Kaptchuk T Kelley JM Conboy LA Components of the Placebo Effect: A randomized controlled trial in irritable bowel syndrome BMJ 2008 336 998 1003 PMC2364862 18390493
  28. [38]Rothschild AJ The diagnosis and treatment of late-life depression J Clin Psychiatry 1996 57 5 11 8647792
  29. [39]Lavretsky H Lesser IM Wohl M Miller BL Mehringer CM Clinical and neuroradiologic features associated with chronicity in late-life depression Am J Geriatr Psychiatry 1999 7 309 316 10521163
  30. [40]Simpson SW Jackson A Baldwin RC Burns A Subcortical hyperintensities in late-life depression: acute response to treatment and neuropsychological impairment Int Psychogeriatr 1997 9 257 275 9513027
  31. [41]O'Brien J Ames D Chiu E Schweitzer I Desmond P Tress B Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow-up study BMJ 1998 317 982 984 9765166 PMC28682
  32. [43]Alexopoulos GS Meyers BS Young RC Kalayam B Kakuma T Gabrielle M Sirey A Hull J Executive dysfunction and long-term outcomes of geriatric depression Arch Gen Psychiatry 2000 57 285 290 10711915
  33. [44]Rohsenow DJ Marlatt GA The Balanced Placebo Design: Methodological Considerations Addict Behav 1981 6 107 122 7023202

Cited by

Sorted by citations

Authors
Rutherford, B. R., Wall, M. M., Brown, P. J., Choo, T.-H., Wager, T. D., Peterson, B. S., Chung, S., Kirsch, I., & Roose, S. P.
Venue
American Journal of Psychiatry
Publisher
American Psychiatric Association Publishing
Published
2017-02-01
Volume
174
Issue
2
Pages
135-142
ISSN
  • 0002-953X
  • 1535-7228
DOI
10.1176/appi.ajp.2016.16020225
PMC
PMC5288269
Cited by
140
References
11
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review